Fresenius Medical Care North America

Fresenius Medical Care North America

Signal active

Investment Firm

Overview

Fresenius Medical Care North America is a hospital and health care company that focuses on providing healthcare services to people with renal and other chronic conditions. It offers dialysis facilities, outpatient cardiac and vascular labs, and urgent care centers.

Fresenius Medical Care North America (FMCNA) is one of the largest providers of dialysis products and services. It has raised a record amount of money to support the goals and initiatives of the National Kidney Foundation (NKF) over the course of a two-year partnership.

Fresenius Medical Care North America was founded in 1996 by Bill Valle and it is headquartered in Waltham, Massachusetts.

Highlights

Founded

1996

Industry

Biotechnology

Employees

10001+

Investment

4

Lead Investment

3

Exits

undefined

Stages

Early Stage Venture

Investor Type

N/A

Location

Waltham, Massachusetts, United States, North America

Contact Information

Social

Profile Resume

Fresenius Medical Care North America, established in 1996 and headquartered in United States, North America., specializes in Early Stage Venture investments across Software, Biotechnology, Hardware, Financial Services, Health Care, Medical Device, Education, mHealth, Enterprise Software, Venture Capital. Their recent investments include Retia Medical, Red Cedar Ventures, BioIntelliSense, 7wire Ventures, iD Ventures America. The highest investment round they participated in was $4.7B. Among their most notable exits are Retia Medical and Red Cedar Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Al Wiegman

Al Wiegman

Head Fresenius Medical Care Ventures GMBH

imagePlace Ravi Kalathil

Ravi Kalathil

Chief Information Officer

imagePlace Franklin Maddux

Franklin Maddux

Chief Medical Officer and Executive Vice President for Clinical and Scientific Affairs

imagePlace Rice Powell

Rice Powell

CEO

imagePlace Bill Valle

Bill Valle

Chief Executive Officer

imagePlace Brian Gauger

Brian Gauger

Chief Development Officer and Senior Vice President

Investment portfolio

Fresenius Medical Care North America has made 4 investments. Their most recent investment was on Jul 18, 2022, when Retia Medical raised $15.0M.

investments

4

Diversity investments

0

Lead investments

3

Number of exits

undefined

Investments

4

Annouced DateOrganization NameIndustryMoney Raised
Jul 09, 2019
BioIntelliSense BioIntelliSense
Biotechnology25.0M
Dec 18, 2019
InterWell Health InterWell Health
Health Care20.0M
Jul 28, 2021
BioIntelliSense BioIntelliSense
Biotechnology45.0M
Jul 18, 2022
Retia Medical Retia Medical
Software15.0M

Exits

0

Funding Timeline

Funding rounds

4

Investors

1

Funds

0

Funding Rounds

4

Fresenius Medical Care North America has raised 4 rounds. Their latest funding was raised on Jul 18, 2022 from a Series B - Retia Medical round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jul 09, 2019
Series A - BioIntelliSense Series A - BioIntelliSense
-25.0M-
Dec 18, 2019
Series A - InterWell Health Series A - InterWell Health
-20.0M-
Jul 28, 2021
Series B - BioIntelliSense Series B - BioIntelliSense
-45.0M-
Jul 18, 2022
Series B - Retia Medical Series B - Retia Medical
-15.0M-

Investors

26

Fresenius Medical Care North America is funded by 26 investor(s). U.S. Department of Veteran Affairs Kantor is the most recent investors.

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries